Keith Katkin Syndax Pharmaceuticals Inc (SNDX) insider trading activity

SNDX Quotes by TradingView

Keith Katkin is of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 65,000 shares of SNDX, which is worth approximately $830,050. The most recent transaction as insider was on Feb 07, 2024, when has been sold 17,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65K
0% 3M change
35.42% 12M change
Total Value Held $830,050

Keith Katkin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2024
BUY
Grant, award, or other acquisition
-
17,000 Added 20.73%
65,000 Common Stock
Feb 02 2023
BUY
Grant, award, or other acquisition
-
16,000 Added 25.0%
48,000 Common Stock
Oct 06 2022
SELL
Open market or private sale
$774,384 $25.9 p/Share
29,899 Reduced 48.3%
32,000 Common Stock
Oct 06 2022
BUY
Exercise of conversion of derivative security
$251,451 $8.41 p/Share
29,899 Added 42.1%
41,117 Common Stock
Oct 04 2022
SELL
Open market or private sale
$9,000 $25.0 p/Share
360 Reduced 1.11%
32,000 Common Stock
Oct 04 2022
BUY
Exercise of conversion of derivative security
$3,028 $8.41 p/Share
360 Added 1.1%
32,223 Common Stock
Oct 03 2022
SELL
Open market or private sale
$4,500 $25.0 p/Share
180 Reduced 0.56%
32,000 Common Stock
Oct 03 2022
BUY
Exercise of conversion of derivative security
$1,514 $8.41 p/Share
180 Added 0.56%
32,013 Common Stock
Sep 30 2022
SELL
Open market or private sale
$89,274 $25.07 p/Share
3,561 Reduced 10.01%
32,000 Common Stock
Sep 30 2022
BUY
Exercise of conversion of derivative security
$29,948 $8.41 p/Share
3,561 Added 9.83%
32,647 Common Stock
Feb 02 2022
BUY
Grant, award, or other acquisition
-
16,000 Added 33.33%
32,000 Common Stock
Feb 03 2021
BUY
Grant, award, or other acquisition
-
16,000 Added 50.0%
16,000 Common Stock

Also insider at

RIGL
RIGEL PHARMACEUTICALS INC Healthcare
Director
ELDN
Eledon Pharmaceuticals, Inc. Healthcare
Director
EBS
Emergent BioSolutions Inc. Healthcare
Director
KK

Keith Katkin

Gaithersburg, MD

Track Institutional and Insider Activities on SNDX

Follow Syndax Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if

News

Receive news related to Syndax Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SNDX